Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Sean P. McBurney"'
Autor:
Shelly J Krebs, Sean P McBurney, Dina N Kovarik, Chelsea D Waddell, J Pablo Jaworski, William F Sutton, Michelle M Gomes, Maria Trovato, Garret Waagmeester, Susan J Barnett, Piergiuseppe DeBerardinis, Nancy L Haigwood
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e113463 (2014)
Developing a vaccine that overcomes the diversity of HIV-1 is likely to require a strategy that directs antibody (Ab) responses toward conserved regions of the viral Envelope (Env). However, the generation of neutralizing Abs (NAbs) targeting these r
Externí odkaz:
https://doaj.org/article/02b9ad27a3cc4e9989f81cdbf0ecf0ed
Autor:
Susan Zolla-Pazner, Miroslaw K. Gorny, Shilpi Pandey, Liuzhe Li, William F. Sutton, Sean P. McBurney, Nancy L. Haigwood, Lily Liu, Ann J. Hessell, Maxim Totrov
Publikováno v:
Vaccine. 34:2713-2721
RV144 vaccinees with low HIV-1 Envelope-specific IgA antibodies (Abs) also had Abs directed to the hypervariable region 3 (V3) that inversely correlated with infection risk. Thus, anti-V3 HIV-1 Abs may contribute to protection from HIV-1 infection. T
Autor:
Tracy Cheever, Delphine C. Malherbe, Sean P. McBurney, Byung Park, Christoph Kahl, Shilpi Pandey, Rebecca L.R. Powell, Nancy L. Haigwood, William F. Sutton, Susan Zolla-Pazner, Mariya B. Shapiro, Ann J. Hessell
Publikováno v:
Journal of virology. 92(11)
A high level of V1V2-specific IgG antibodies (Abs) in vaccinees' sera was the only independent variable that correlated with a reduced risk of human immunodeficiency virus (HIV) acquisition in the RV144 clinical trial. In contrast, IgG avidity, antib
Autor:
Amanda Pfaff Smith, Jared D. Evans, Ernesto T. A. Marques, Neel K. Krishna, Sean P. McBurney, Eduardo J. M. Nascimento, Bruno Douradinha, Simon M. Barratt-Boyes, Klecia M. Soares de Melo
Publikováno v:
Virus Research. 179:231-234
Dengue virus infection elicits a spectrum of clinical presentations ranging from asymptomatic to severe disease. The mechanisms leading to severe dengue are not known, however it has been reported that the complement system is hyper-activated in seve
Autor:
Jared D. Evans, Tatiana M. Garcia-Bates, Simon M. Barratt-Boyes, Klecia M. Soares de Melo, Eduardo J. M. Nascimento, Sean P. McBurney, Ernesto T. A. Marques, Marli Tenório Cordeiro, Amanda Pfaff Smith
Publikováno v:
The Journal of Immunology. 190:80-87
Dengue is a globally expanding disease caused by infection with dengue virus (DENV) that ranges from febrile illness to acute disease with serious complications. Secondary infection predisposes individuals to more severe disease, and B lymphocytes ma
Autor:
Nancy L. Haigwood, Sean P. McBurney, Rossella Sartorius, Fausta Cuccaro, Valerio Costa, Antonella Prisco, Mauro Rossi, Piergiuseppe De Berardinis, Maria Trovato, Luciana D'Apice, Shelly J. Krebs, Francesco Maurano, Alfredo Ciccodicola
Publikováno v:
BMC Microbiology (Online) (2016). doi:10.1186/s12866-016-0772-x
info:cnr-pdr/source/autori:Trovato M, Maurano F, D'Apice L, Costa V, Sartorius R, Cuccaro F, McBurney SP, Krebs SJ, Prisco A, Ciccodicola A, Rossi M, Haigwood NL, De Berardinis P./titolo:E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells./doi:10.1186%2Fs12866-016-0772-x/rivista:BMC Microbiology (Online)/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume
BMC Microbiology
info:cnr-pdr/source/autori:Trovato M, Maurano F, D'Apice L, Costa V, Sartorius R, Cuccaro F, McBurney SP, Krebs SJ, Prisco A, Ciccodicola A, Rossi M, Haigwood NL, De Berardinis P./titolo:E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells./doi:10.1186%2Fs12866-016-0772-x/rivista:BMC Microbiology (Online)/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume
BMC Microbiology
BACKGROUND: The E2 multimeric scaffold represents a powerful delivery system able to elicit robust humoral and cellular immune responses upon systemic administrations. Here recombinant E2 scaffold displaying the third variable loop of HIV-1 Envelope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8358884a2a8f3624e986ce52adf35931
https://publications.cnr.it/doc/363950
https://publications.cnr.it/doc/363950
Publikováno v:
McBurney, Sean P.; Landucci, Gary; Forthal, Donald N.; & Ross, Ted M.(2012). Evaluation of Heterologous Vaginal SHIV SF162p4 Infection Following Vaccination with a Polyvalent Clade B Virus-Like Particle Vaccine. AIDS Research and Human Retroviruses, 28(9), 863-872. UC Irvine: Institute for Clinical and Translational Science. Retrieved from: http://www.escholarship.org/uc/item/2014j63g
The vast diversity of HIV-1 infections has greatly impeded the development of a successful HIV-1/AIDS vaccine. Previous vaccine work has demonstrated limited levels of protection against SHIV/SIV infection, but protection was observed only when the c
Autor:
Ted M. Ross, Sean P. McBurney
Publikováno v:
Expert Review of Vaccines. 7:1405-1417
Among the greatest challenges facing AIDS vaccine development is the intrinsic diversity among circulating populations of HIV-1 in various geographical locations and the need to develop vaccines that can elicit enduring protective immunity to variant
Publikováno v:
Virology. 358:334-346
Virally regulated HIV-1 particles were expressed from DNA plasmids encoding Gag, protease, reverse transcriptase, Vpu, Tat, Rev, and Env. The sequences for integrase, Vpr, Vif, Nef, and the long terminal repeats (LTRs) were deleted. Mutations were en
Autor:
Nancy L. Haigwood, Celia C. LaBranche, Matthew D. Gray, Deborah H. Fuller, Delphine C. Malherbe, Ann J. Hessell, Michelle M. Gomes, Harlan Robins, Franco Pissani, Byung Park, Leonidas Stamatatos, Shelly J. Krebs, Shilpi Pandey, Jonah B. Sacha, D. Noah Sather, William F. Sutton, Benjamin J. Burwitz, David C. Montefiori, Sean P. McBurney
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 196(7)
Advancement in immunogen selection and vaccine design that will rapidly elicit a protective Ab response is considered critical for HIV vaccine protective efficacy. Vaccine-elicited Ab responses must therefore have the capacity to prevent infection by